← FDA Drug Approvals (Drugs@FDA)
NALOXONE HYDROCHLORIDE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: TEVA PHARMS USA · Approved 2019-04-19
Drug application
- FDA Application #
ANDA209522- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- NALOXONE HYDROCHLORIDE
- Generic name
- NALOXONE HYDROCHLORIDE
- Active ingredients
- NALOXONE HYDROCHLORIDE
- Dosage form
- SPRAY, METERED
- Route
- NASAL
- Marketing status
- Over-the-counter
- Sponsor
- TEVA PHARMS USA
- Manufacturer
- Teva Pharmaceuticals USA, Inc.
- First approval
- 2019-04-19
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown